Hyperinsulinemia Rapidly Increases Human Muscle
Microvascular Perfusion but Fails to Increase Muscle
Insulin Clearance
Evidence That a Saturable Process Mediates Muscle
Insulin Uptake
Emma M. Eggleston, Linda A. Jahn, and Eugene J. Barrett
OBJECTIVE— Transport of insulin from the central circulation
into muscle is rate limiting for the stimulation of glucose
metabolism. By recruiting muscle microvasculature, insulin may
promote its own movement into muscle interstitium. We tested
whether in humans, as in the rat, insulin exerts an early action to
recruit microvasculature within skeletal muscle. We further
hypothesized that expansion of the microvascular volume of
muscle would enhance muscle insulin clearance.
RESEARCH DESIGN AND METHODS— Microvascular vol-
ume, total blood flow, and muscle insulin and glucose uptake
(forearm balance method) were measured in 14 lean, healthy
volunteers before and during a 2-h hyperinsulinemic-euglycemic
clamp (1 mU kg
-1
min
-1
). Microvascular volume was mea-
sured using contrast-enhanced ultrasound.
RESULTS— Forearm muscle microvascular volume increased
within 20 min of insulin infusion (P 0.01), whereas an effect to
increase total forearm flow was not observed until 100 min.
Forearm insulin uptake increased with physiological hyperinsu-
linemia (15 3 and 87 13 fmol min
-1
100 ml
-1
basal vs. last
40 min of clamp, P 0.001). However, the extraction fraction
and clearance of insulin declined (P = 0.02, for each), indicating
saturability of muscle insulin uptake at physiological hyperinsu-
linemia.
CONCLUSIONS— Skeletal muscle contributes to peripheral
insulin clearance both in the basal state and with physiological
hyperinsulinemia. Insulin promptly expands human muscle mi-
crovascular volume but only slowly increases blood flow. De-
spite increased microvascular volume available for insulin
uptake, muscle insulin clearance decreases significantly. These
findings are consistent with the presence of a saturable transport
mechanism facilitating the transendothelial transport of insulin
into human muscle. Diabetes 56:2958–2963, 2007
A
number of studies have demonstrated that
insulin enhances skeletal muscle blood flow
and suggest that changes in muscle perfusion
play a role in regulating muscle glucose dis-
posal (1,2). The potential importance of muscle perfusion
for the delivery of insulin to muscle is underscored by
studies demonstrating that in muscle, glucose metabolism
correlates more strongly with interstitial than with plasma
insulin levels (3,4) and by considerable evidence that the
transendothelial transport of insulin is rate limiting for its
action on muscle glucose metabolism (3,5–7). Studies
using lymphatic sampling or microdialysis to quantify
interstitial insulin concentrations consistently demon-
strate 1) a significant time delay between increases in
interstitial versus arterial insulin concentrations (3,6,8)
and 2) the presence of a persistent (approximately two-
fold) concentration gradient between interstitial and
plasma insulin concentrations both basally (3,9,10) and
during steady-state hyperinsulinemia (3,7,9,11).
The large majority of muscle endothelial surface area
resides in capillaries and precapillary arterioles. How-
ever, only 25% of skeletal muscle microvasculature is
perfused at rest. Expanding the microvascular surface
area perfused within muscle would proportionately
increase the opportunity for insulin and glucose ex-
change across the skeletal muscle bed. Our laboratory
has demonstrated that insulin increases capillary perfu-
sion within muscle by recruiting microvasculature (12–
14). This recruitment appears to be due to relaxation of
terminal arterioles, which, like the relaxation of resis-
tance vessels by insulin, is sensitive to inhibition of
nitric oxide synthase and is diminished by insulin
resistance (15,16). In the rat, insulin increases micro-
vascular perfusion within 10 –15 min. This increase
temporally precedes changes in both glucose utilization
and total blood flow (14) and suggests that insulin
actively regulates its own delivery to the capillary
endothelium. However, the time course for insulin-
mediated microvascular recruitment in humans is not
known.
In the current study, we used contrast-enhanced ultra-
sound (CEU) to ascertain whether in humans, as in the rat,
insulin exerts an early action to recruit microvasculature
within skeletal muscle. We further hypothesized that if
insulin did expand the microvascular volume available for
perfusion within skeletal muscle, enhanced muscle insulin
From the University of Virginia Health System, Charlottesville, Virginia.
Address correspondence and reprint requests to Emma M. Eggleston,
University of Virginia Health System, P.O. Box 801410, 450 Ray C. Hunt Dr.,
Charlottesville, VA 22908. E-mail: ebm2n@virginia.edu.
Received for publication 18 May 2007 and accepted in revised form 23
August 2007.
Published ahead of print at http://diabetes.diabetesjournals.org on 24 Au-
gust 2007. DOI: 10.2337/db07-0670.
CEU, contrast-enhanced ultrasound; MBV, microvascular blood volume.
© 2007 by the American Diabetes Association.
The costs of publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked “advertisement” in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
ORIGINAL ARTICLE
2958 DIABETES, VOL. 56, DECEMBER 2007